Skip to content

Confusion continues at CROI over triple nuke therapy (amended)

Doctors rebellion against ritonavir price increase spreads in US

Opportunities and challenges on the route to effective microbicides

PEP for sexual exposure to HIV not 100% effective

Tarnished glitazones fail to reverse fat wasting

HAART clinically and immunologically effective in babies but high rate of virologic failure

Allergic reaction to abacavir reported after treatment break, one year after starting the drug

Nevirapine should not be used for PEP confirms US review

Meta-analysis finds PI-based HAART better than NNRTI regimens in NRTI experienced